Long-Term Survival with Whole Abdominopelvic Irradiation in Platinum-Refractory Persistent or Recurrent Ovarian Cancer

Author： Cmelak A.J.   Kapp D.S.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.65, Iss.3, 1997-06, pp. : 453-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No Rules without Exception: Long-Term Complete Remission Observed in a Study Using a LH-RH Agonist in Platinum-Refractory Ovarian Cancer

By Paskeviciute L.   Roed H.   Engelholm S.A.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 297-301

Academic Press

Access to resources Recommend Favorite

Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary Report

By Markman M.   Iseminger K.A.   Hatch K.D.   Creasman W.T.   Barnes W.   Dubeshter B.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 4-6

Academic Press

Access to resources Recommend Favorite

Phase II Trial of CI-958 in Recurrent Platinum-Refractory Ovarian Carcinoma - A Gynecologic Oncology Group Study

By Hoffman M.A.   Blessing J.A.   Morgan M.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 463-465

Elsevier

Access to resources Recommend Favorite

''Recurrence within 6 Months of Platinum Therapy'': An Adequate Definition of ''Platinum-Refractory'' Ovarian Cancer?

By Markman M.  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 91-92

Elsevier

Access to resources Recommend Favorite

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

By Markman M.   Blessing J.A.   Moore D.   Ball H.   Lentz S.S.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 226-229

Elsevier

Access to resources Recommend Favorite